These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Pharmacodynamics and pharmacokinetics of enprofylline and theophylline in the isolated rabbit heart. Nielsen-Kudsk JE, Askholt J. Pharmacol Toxicol; 1988 Sep; 63(3):183-8. PubMed ID: 3186628 [Abstract] [Full Text] [Related]
33. Theophylline-induced recovery in a hemidiaphragm paralyzed by hemisection in rats: contribution of adenosine receptors. Nantwi KD, Goshgarian HG. Neuropharmacology; 1998 Sep; 37(1):113-21. PubMed ID: 9680264 [Abstract] [Full Text] [Related]
34. Effects of enprofylline on A1 and A2 adenosine receptors. Ukena D, Schirren CG, Schwabe U. Eur J Pharmacol; 1985 Oct 29; 117(1):25-33. PubMed ID: 3002801 [Abstract] [Full Text] [Related]
36. Enprofylline and theophylline on small human placental arteries: studies of in vitro effects and mode of action. Nielsen-Kudsk JE. Acta Pharmacol Toxicol (Copenh); 1985 Feb 29; 56(2):176-82. PubMed ID: 3993386 [Abstract] [Full Text] [Related]
37. Ciglitazone, a peroxisome proliferator-activated receptor gamma inducer, ameliorates renal preglomerular production and activity of angiotensin II and thromboxane A2 in glycerol-induced acute renal failure. Yousefipour Z, Hercule H, Truong L, Oyekan A, Newaz M. J Pharmacol Exp Ther; 2007 Aug 29; 322(2):461-8. PubMed ID: 17494862 [Abstract] [Full Text] [Related]